GlaxoSmithKline Pays to Settle FCPA Violations

Posted 11/11/16

And so it becomes a routine part of doing business. UK-based pharmaceutical company GlaxoSmithKline plc (GSK) agreed Sept. 30, 2016, to pay a $20 million civil penalty to settle charges it violated …

This item is available in full to subscribers.

Please log in to continue

Log in